10x Genomics (TXG) Non-Current Debt (2018 - 2019)
10x Genomics recorded quarterly Non-Current Debt of $19.8 million in Q4 2019, down 11.07% quarter-over-quarter from $22.3 million in Q3 2019, and down 22.17% year-over-year from $25.5 million in Q4 2018.
10x Genomics' Non-Current Debt history runs 2 years deep, the most recent figure standing at $19.8 million for Q4 2019.
- In Q4 2019, Non-Current Debt fell 22.17% year-over-year to $19.8 million; the TTM figure through Dec 2019 stood at $19.8 million (down 22.17% YoY), while the FY2019 annual figure was $19.8 million, down 22.17% from the prior year.
- Non-Current Debt came in at $19.8 million for Q4 2019 at 10x Genomics, down from $22.3 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $25.5 million in Q4 2018 to a low of $19.8 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.44 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 942.66 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 1.46 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 19.84 Mn |
| Dec 31, 2019 | 19.84 Mn |
| Sep 30, 2019 | 22.31 Mn |
| Sep 30, 2019 | 22.31 Mn |
| Dec 31, 2018 | 25.49 Mn |
| Dec 31, 2018 | 25.49 Mn |